Decreased bombesin peptide response to cigarette smoking in schizophrenia

Neuropsychopharmacology

Volumn 20, Issue 1, 1999, Pages 52-59

  Olincy, Ann ^a   Leonard, Sherry ^a,c   Young, David A ^b   Sullivan, Bernadette ^a   Freedman, Robert ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Dept of Prev Med and Biometrics ^*  (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Gastrin releasing peptide; Neuroendocrine cells; Nicotine; Nicotinic receptors; Pulmonary inflammation; Tobacco

Indexed keywords

ACETYLCHOLINE; BOMBESIN; BOMBESIN LIKE PEPTIDE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LUNG CANCER; NEUROPHARMACOLOGY; NEUROSECRETORY CELL; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; BOMBESIN; FEMALE; HUMANS; MALE; PEPTIDES; SCHIZOPHRENIA; SMOKING;

EID: 0032950449     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00053-0     Document Type: Article

References (42)

1. Adler L.E., Hoffer L.J., Griffith J., Waldo M., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiat. 32:1992;607-616.
2. Adler L.E., Hoffer L.J., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiat. 150:1993;1856-1861.
3. Aguayo S.M., King T.E., Waldron J.A., Sherritt K.M., Kane M.A., Miller Y.E. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophillic granuloma. J Clin Ivest. 86:1990;838-844.
4. Aguayo S.M., King T.E., Kane M.A., Sherritt K.M., Silvers W., Nett L.M., Petty T.L., Miller Y.E. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers. A potential risk marker for smoking-related diseases Cancer Res. 52:1992;2727s-2731s.
5. Aguayo S.M. Pulmonary neuroendocrine cells in tobacco-related lung disorders. Anat Rec. 236:1993;122-127.
6. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3:1987;American Psychiatric Association, Washington, DC.
7. Baldwin J.A. Schizophrenia and physical disease. Psychol Med. 9:1979;611-618.
8. Chan J., Quik M. A role for the nicotinic α-bungarotoxin receptor in nurite outgrowth in PC12 cells. Neuroscience. 56:1993;441-451.
9. Codignola A., Tarroni P., Cattaneo M.G., Vicentini L.M., Clementi F., Sher E. Serotonin release and cell proliferation are under the control of α-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines. FEBS Lett. 342:1994;286-290.
10. Craig T.J., Lin S.P. Cancer and mental illness. Compr Psychiat. 22:1981;404-410.
11. Cuittita F., Carney D.N., Mulshine J., Moody T.W., Fedorko J., Fishler A., Minna J.D. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature. 316:1985;823-826.
12. Dalack G.W., Glassman A.H. A clinical approach to help psychiatric patients with smoking cessation. Psychiatr Q. 63:1992;27-39.
13. de Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking. An epidemiological survey in a state hospital Am J Psychiat. 152:1995;453-455.
14. Endicott J., Andreasen N., Spitzer R.L. Family History-Research Diagnostic Criteria. 3:1978;Research Assessment and Training Unit, New York. New York State Psychiatric Institute.
15. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for deceased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiat. 38:1995;22-33.
16. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D., Breese C., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592.
17. Glassman A.H. Cigarette smoking. implication for psychiatric illness Am J Psychiat. 150:1993;546-553.
18. Gerner R.H., Yamada T. Altered neuropeptide concentration in cerebral spinal fluid of psychiatric patients. Brain Res. 238:1982;298-302.
19. Gerner R.H., Van Kammen D.P., Ninan P.T. Cerebrospinal fluid cholecystokinin, bombesin, and somatostatin in schizophrenia and normals. Prog Neuropsychopharmacol Biol Psychiat. 9:1985;73-82.
20. Gulbinat W., Dupont A., Jablensky A., Jensen O.M., Marsella A., Nakane Y., Sartorius N. Cancer incidence of schizophrenic patients results of record linkage studies in three countries. Br J Psychiat. 161:1992;75-85.
21. Hecht S.S., Hoffman D. Tobacco-specific nitrosamines, and important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:1988;875-884.
22. Jarvis M.J., Russell M.A.H., Saloojee Y. Expired air carbon monoxide. A simple breath test for tobacco smoke intake BMJ. 288:1980;484-485.
23. Johnson C.E., Lock J.E., Elde R.P., Thompson T.R. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia. Pediatr Res. 16:1982;446-454.
24. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophr Res. 8:1992;93-102.
25. Kane M.A., Aguayo S.M., Portanova L.B., Ross S.E., Holley M., Kelley K., Miller Y.E. Isolation of the bombesin/gastrin-releasing peptide receptor from human small cell lung carcinoma NCI-H354 cells. J Biol Chem. 266:1991;9486-9493.
26. Lynn R.B., Hyde T.M., Cooperman R.R., Miselis R.R. Distribution of bombesin-like immunoreactivity in the nucleus of the solitary tract and dorsal motor nucleus of the rat and human. Colocalization with tyrosine hydroxylase J Comp Neurol. 369:1996;552-570.
27. McEvoy J.P., Freudenreich O., Levin E.D., Rose J.E. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology. 119:1995;124-126.
28. Masterson E., O'Shea B. Smoking and malignancy in schizophrenia. Br J Psychiatr. 145:1984;429-432.
29. Minna J.D. The molecular biology of lung cancer pathogenesis. Chest. 103:1993;445s-456s.
30. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiat. 42:1997;1-5. a.
31. Olincy A., Ross R.G., Leonard S., Freedman R. Preliminary linkage of eye movement abnormalities in schizophrenia. Soc Biolog Psychiat. 41:1997;84S. b.
32. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 18:1998;175-185.
33. Quik M., Chan J., Patrick J. α-bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655:1994;161-167.
34. Rassidakis N.C., Kelepouris M., Goulis R., Karaiossefidis K. Malignant neoplasm as a cause of death among psychiatric patients. Internat Ment Hlth Res Newslett. 14:1971;1.
35. Rice D. No lung cancer in schizophrenics? Br J Psychiat. 134:1979;128.
36. Scheubert M.L., Makhlouf G.M. Neural, hormonal, and paracrine regulation of gastrin and acid secretion. Yale J Biol Med. 65:1992;553-560.
37. Scheurman D.W., Adrioaensen D., Timmermans J.P., DeGroodt-Lasseel M.H. Comparative histological overview of the chemical coding of the pulmonary neuroepithelial endocrine system in health and disease. Eur J Morphol. 30:1992;101-112.
38. Schuller H.M. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem Pharmacol. 38:1989;3439-3442.
39. Schuller H.M., Nylen E., Park P., Becker K.L. Nicotine, acetylcholine, and bombesin are trophic growth factors in neuroendocrin cell lines derived from experimental hamster lung tumors. Life Sci. 47:1990;571-578.
40. Snedecor GW, Cochran WG (1989): Statistical Methods. Ames, Iowa, Iowa State University Press.
41. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R - Nonpatient Edition (SCID-NP, Version 1.0). 1990;American Psychiatric Press, Washington, DC.
42. Zucker K.A., Longo W.E., Modlin I.M., Bilchik A.J., Adrian T.E. Malignant diathesis from jejunal-ilieal carcinoids. Am J Gastroenterol. 84:1989;182-186.